Dieses Bild zeigt  Yvonne Aidee Montes Mojarro

Frau Dr. med.

Yvonne Aidee Montes Mojarro

Clinician Scientist C3
Eberhard Karls Universität Tübingen
Universitätsklinikum, Institut für Pathologie und Neuropathologie
[Foto: Ivonne Montes, Institut für Pathologie und Neuropathologie]

Kontakt

+49 7071-29-84928
+49 7071-29-2258

Liebermeisterstraße 8
72076 Tübingen
Deutschland

Publikationen

 

   

·         Vogelsberg, A.; Steinhilber, J.; Mankel, B.; Federmann, B.; Schmidt, J.; Montes-Mojarro, I.A.; Huttl, K.; Rodriguez-Pinilla, M.; Baskaran, P.; Nahnsen, S., et al. Genetic evolution of in situ follicular neoplasia to aggressive B-cell lymphoma of germinal center subtype. Haematologica 2020, 10.3324/haematol.2020.254854, doi:10.3324/haematol.2020.254854.

·         Prokoph, N.; Probst, N.A.; Lee, L.C.; Monahan, J.M.; Matthews, J.D.; Liang, H.C.; Bahnsen, K.; Montes-Mojarro, I.A.; Karaca-Atabay, E.; Sharma, G.G., et al. IL10RA modulates crizotinib sensitivity in NPM1-ALK+ anaplastic large cell lymphoma. Blood 2020, 136, 1657-1669, doi:10.1182/blood.2019003793.

·         Montes-Mojarro, I.A.; Kim, W.Y.; Fend, F.; Quintanilla-Martinez, L. Epstein - Barr virus positive T and NK-cell lymphoproliferations: Morphological features and differential diagnosis. Semin Diagn Pathol 2020, 37, 32-46, doi:10.1053/j.semdp.2019.12.004.

·         Montes-Mojarro, I.A.; Chen, B.J.; Ramirez-Ibarguen, A.F.; Quezada-Fiallos, C.M.; Perez-Baez, W.B.; Duenas, D.; Casavilca-Zambrano, S.; Ortiz-Mayor, M.; Rojas-Bilbao, E.; Garcia-Rivello, H., et al. Mutational profile and EBV strains of extranodal NK/T-cell lymphoma, nasal type in Latin America. Mod Pathol 2020, 33, 781-791, doi:10.1038/s41379-019-0415-5.

·         Kim, W.Y.; Montes-Mojarro, I.A.; Fend, F.; Quintanilla-Martinez, L. Epstein-Barr Virus-Associated T and NK-Cell Lymphoproliferative Diseases. Front Pediatr 2019, 7, 71, doi:10.3389/fped.2019.00071.

·         Loffler, M.W.; Steinhilber, J.; Hilke, F.J.; Haen, S.P.; Bosmuller, H.; Montes-Mojarro, I.A.; Bonzheim, I.; Stabler, A.; Faust, U.; Grasshoff, U., et al. First case report of malignant peritoneal mesothelioma and oral verrucous carcinoma in a patient with a germline PTEN mutation: a combination of extremely rare diseases with probable further implications. BMC Med Genet 2018, 19, 144, doi:10.1186/s12881-018-0651-4.

·         Montes-Mojarro, I.A.; Steinhilber, J.; Bonzheim, I.; Quintanilla-Martinez, L.; Fend, F. The Pathological Spectrum of Systemic Anaplastic Large Cell Lymphoma (ALCL). Cancers (Basel) 2018, 10, doi:10.3390/cancers10040107.

·         Montes-Mojarro, I.; Baquera-Heredia, J.; Felipe Sanchez-Marle, J.; Ortiz-Hidalgo, C. Immunohistochemical Expression of Nuclear beta-Catenin and STAT-6 in a Solitary Fibrous Tumor of the Soft Palate: A Case Report and Review of the Literature. Iran J Pathol 2017, 12, 281-285.

·         Schmidt, J.; Bonzheim, I.; Steinhilber, J.; Montes-Mojarro, I.A.; Ortiz-Hidalgo, C.; Klapper, W.; Fend, F.; Quintanilla-Martinez, L. EMMPRIN (CD147) is induced by C/EBPbeta and is differentially expressed in ALK+ and ALK- anaplastic large-cell lymphoma. Lab Invest 2017, 97, 1095-1102, doi:10.1038/labinvest.2017.54.

·         Schmidt, J.; Ramis-Zaldivar, J.E.; Nadeu, F.; Gonzalez-Farre, B.; Navarro, A.; Egan, C.; Montes-Mojarro, I.A.; Marafioti, T.; Cabecadas, J.; van der Walt, J., et al. Mutations of MAP2K1 are frequent in pediatric-type follicular lymphoma and result in ERK pathway activation. Blood 2017, 130, 323-327, doi:10.1182/blood-2017-03-776278.

·         Bonifacio-Delgadillo, D.; Aburto-Murrieta, Y.; Salinas-Lara, C.; Sotelo, J.; Montes-Mojarro, I.; Garcia-Marquez, A. Clinical presentation and magnetic resonance findings in sellar tuberculomas. Case Rep Med 2014, 2014, 961913, doi:10.1155/2014/961913.

 

Studium

  • 2013 - 2016 Facharzt für Pathologie, ABC Medical Center, National Autonomous University of Mexico (UNAM)
  • Mex. Berufserlaubnis als Pathologin
  • 2015 Ausbildungsrotation (3 Monate) in der Hämatopathologie, "Marqués de Valdecilla" University Hospital (Santander, Spanien)
  • 2010 - 2012 Masterstudium in Health Science, Schwerpunkt Immunologie
  • 2010 - 2011 Zivildienst, Department of Neuropathology
  • 2004 - 2010 Studium der Humanmedizin, Universidad de Guadalajara
  • 2009 - 2010 Praktisches Jahr, National Institute of Medical Sciences and Nutrition "Salvador Zubirán"

Promotion

  • 2016 bis heute: Experimentelle Medizin - PhD, Titel: The role of CEBPß regulated miRNAs in ALK + Anaplastic Large Cell Lymphoma, Doktorvater: Prof. Dr. Falko Fend, Eberhard Karls Universität Tübingen
  • 2017 bis heute: Promotion in der Humanmedizin (Dr. Med.), Molecular analysis of extranodal NK/T-cell lymphoma, nasal type in Latin Amerika, Doktormutter: Prof. Dr. Leticia Quintanilla-Fend, Eberhard Karls Universität Tübingen

Beruflicher Werdegang

  • 2011 - 2012 Dozent für Theorie und Praxis der medizinischen Immunologie, Graduate School of Medicine, National Polytechnic Institute (IPN)
  • 2011 - 2012 Dozent für Theorie der medizinischen Immunologie, Iztacala School of Advanced Studies, Autonomous University of Mexico
Zum Seitenanfang